Cover Image
市場調查報告書

PhytoHealth Corporation(懷特生技新藥股份有限公司):產品平台分析

PhytoHealth Corporation - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 259361
出版日期 內容資訊 英文 25 Pages
訂單完成後即時交付
價格
Back to Top
PhytoHealth Corporation(懷特生技新藥股份有限公司):產品平台分析 PhytoHealth Corporation - Product Pipeline Review - 2015
出版日期: 2015年09月16日 內容資訊: 英文 25 Pages
簡介

PhytoHealth Corporation 是 Maywufa Biopharma Group 的子公司,開發、製造、銷售腦血管疾病、C型肝炎、暈車、骨質疏鬆症等治療藥的生物科技企業。該公司也致力於植物藥及新化學物質藥的開發,也提供癌症相關的疲勞、腎臟病、急性缺血症、中風的治療藥、止痛藥等。總公司在台灣的台北。

本報告提供PhytoHealth Corporation 的治療藥開發平台的現狀及各開發階段比較分析,各藥物標的、作用機制、給藥途徑、分子類型的治療藥的評估相關資訊等。

PhytoHealth Corporation的基本資料

  • PhytoHealth Corporation概要
  • 主要資訊
  • 企業資料

PhytoHealth Corporation:R&D概要

  • 主要的治療範圍

PhytoHealth Corporation:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

PhytoHealth Corporation:開發中產品概況

  • 最後階段的開發中產品
    • 第三階段的產品/聯合治療模式
  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第0階段的產品/聯合治療模式

PhytoHealth Corporation:藥物簡介

PhytoHealth Corporation:開發平台分析

  • 各標靶
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

PhytoHealth Corporation:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07587CDB

Summary

Global Markets Direct's, 'PhytoHealth Corporation - Product Pipeline Review - 2015', provides an overview of the PhytoHealth Corporation's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of PhytoHealth Corporation's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of PhytoHealth Corporation including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of PhytoHealth Corporation's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the PhytoHealth Corporation's pipeline products

Reasons to buy

  • Evaluate PhytoHealth Corporation's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of PhytoHealth Corporation in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the PhytoHealth Corporation's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of PhytoHealth Corporation and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of PhytoHealth Corporation
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of PhytoHealth Corporation and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • PhytoHealth Corporation Snapshot
    • PhytoHealth Corporation Overview
    • Key Information
    • Key Facts
  • PhytoHealth Corporation - Research and Development Overview
    • Key Therapeutic Areas
  • PhytoHealth Corporation - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • PhytoHealth Corporation - Pipeline Products Glance
    • PhytoHealth Corporation - Late Stage Pipeline Products
      • Phase III Products/Combination Treatment Modalities
    • PhytoHealth Corporation - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase 0 Products/Combination Treatment Modalities
  • PhytoHealth Corporation - Drug Profiles
    • nalbuphine hydrochloride
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PHN-013
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PHN-014
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PHN-031
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PHN-033
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PHN-015
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • PhytoHealth Corporation - Pipeline Analysis
  • PhytoHealth Corporation - Pipeline Products by Target
  • PhytoHealth Corporation - Pipeline Products by Route of Administration
  • PhytoHealth Corporation - Pipeline Products by Molecule Type
  • PhytoHealth Corporation - Pipeline Products by Mechanism of Action
  • PhytoHealth Corporation - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • PhytoHealth Corporation, Key Information
  • PhytoHealth Corporation, Key Facts
  • PhytoHealth Corporation - Pipeline by Indication, 2015
  • PhytoHealth Corporation - Pipeline by Stage of Development, 2015
  • PhytoHealth Corporation - Monotherapy Products in Pipeline, 2015
  • PhytoHealth Corporation - Phase III, 2015
  • PhytoHealth Corporation - Phase II, 2015
  • PhytoHealth Corporation - Phase 0, 2015
  • PhytoHealth Corporation - Pipeline by Target, 2015
  • PhytoHealth Corporation - Pipeline by Route of Administration, 2015
  • PhytoHealth Corporation - Pipeline by Molecule Type, 2015
  • PhytoHealth Corporation - Pipeline Products by Mechanism of Action, 2015
  • PhytoHealth Corporation, Other Locations

List of Figures

  • PhytoHealth Corporation - Pipeline by Top 10 Indication, 2015
  • PhytoHealth Corporation - Pipeline by Stage of Development, 2015
  • PhytoHealth Corporation - Monotherapy Products in Pipeline, 2015
  • PhytoHealth Corporation - Pipeline by Top 10 Target, 2015
  • PhytoHealth Corporation - Pipeline by Top 10 Route of Administration, 2015
  • PhytoHealth Corporation - Pipeline by Top 10 Molecule Type, 2015
  • PhytoHealth Corporation - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top